Certified by Founder
Lodge
HepaRegeniX GmbH
start up

- 16/04/2025
- Unknown
- $24,359,707
HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases.
- Industry Biotechnology Research
- Website https://www.heparegenix.com/
- LinkedIn https://www.linkedin.com/company/heparegenix-gmbh/